Skip to main content
logo
ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
8.81
+0.18 (2.09%)
At close: Oct 28, 2026, 4:00 PM EDT
8.79
-0.02 (-0.23%)
Pre-market: Oct 29, 2026, 5:26 AM EDT

ImmunityBio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
165.79113.2914.750.620.240.93
Revenue Growth
192.92%668.32%2270.58%159.17%-74.30%54.38%
Gross Profit
164.7112.5414.750.620.240.93
Operating Income
-251.8-256.03-344.18-361.36-350.67-317.42
Net Income
-992.36-351.4-413.56-583.2-416.57-346.79
Earnings Per Share
-0.99-0.38-0.62-1.15-1.04-0.89
EPS Growth
------

Revenue by Segment
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Product
164.89112.9814.15---
Other
0.90.310.60.620.240.93
Revenue (Total)
165.79113.2914.750.620.240.93

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
357.37242.82149.81267.35108.02317.94
Total Debt
1,228844.72789.82883.68725.33648.26
Net Cash (Debt)
-871.03-601.9-640.01-616.32-617.31-330.32
Net Cash Growth
------
Net Cash Per Share
-0.87-0.65-0.91-1.21-1.54-0.85

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-281.14-304.94-391.24-366.76-337.51-274.42
Capital Expenditures
-6.94-3.85-6.89-30.58-78.16-33.56
Free Cash Flow
-288.07-308.78-398.12-397.34-415.67-307.98
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
99.34%99.33%100.00%100.00%100.00%100.00%
Operating Margin
-151.88%-226.00%-2334.23%-58097.11%-146111.67%-33985.44%
Pretax Margin
-598.69%-310.37%-2805.32%-93873.31%-173869.17%-37456.00%
Profit Margin
-598.55%-310.18%-2804.77%-93761.41%-173569.58%-37129.55%
FCF Margin
-173.76%-272.56%-2700.06%-63881.19%-173196.25%-32974.52%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
56.3217.22126.775388.888648.472589.53